HURA

TuHURA BIOSCIENCES, INC./NV

Company Overview

TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.

SectorHealthcare

IndustryBiotechnology

Market Cap$138.9M

Last DividendNone

Employees22

CEOJames A. Bianco

Websitehttp://www.tuhurabio.com

Valuation

Current Price$2.18

Fair Value?$000.00

Valuation?No valuation

Current PE ?N/Aⓘ

Hist. PE ?N/Aⓘ

EPS (TTM) ?-0.48

Forward EPS Growth ?—

Historical Growth ?61.04%

Equity, FCF, Long Term Debt, Net Profit, and Shares Outstanding history charts are available on the Pro plan for just $9.99/month.Sign in to unlock Pro

Price?

EPS?

Revenue?

Equity?

Pro

Available on the Pro plan

Free Cash Flow?

Pro

Available on the Pro plan

Long Term Debt?

Pro

Available on the Pro plan

Net Profit?

Pro

Available on the Pro plan

Shares Outstanding?

Pro

Available on the Pro plan

Last updated: 10/23/2026, 10:56:16 PM